Dr. Stewart Goldman, MD
Claim this profileLurie Children's Hospital-Chicago
Area of expertise
Brain Tumor
Stewart Goldman, MD has run 11 trials for Brain Tumor. Some of their research focus areas include:
Diffuse Intrinsic Pontine Glioma
Stewart Goldman, MD has run 5 trials for Diffuse Intrinsic Pontine Glioma. Some of their research focus areas include:
Affiliated Hospitals
Lurie Children's Hospital-Chicago
Ann & Robert H Lurie Children's Hospital Of Chicago
Clinical Trials Stewart Goldman, MD is currently running
PARP Inhibitor + Temozolomide
for Brain Cancer
This trial studies the safety and best dose of BGB-290 and temozolomide in treating young people with a specific type of brain tumor. BGB-290 blocks enzymes needed for tumor growth, while temozolomide kills or stops cancer cells from growing. The goal is to find out if this combination works better for these patients.
Recruiting
1 award
Phase 1
Antiangiogenic Therapy
for Pediatric Brain Cancer
Patients with relapsed medulloblastoma, ependymoma and ATRT have a very poor prognosis whether treated with conventional chemotherapy, high-dose chemotherapy with stem cell rescue, irradiation or combinations of these modalities. Antiangiogenetic therapy has emerged as new treatment option in solid malignancies. The frequent, metronomic schedule targets both proliferating tumor cells and endothelial cells, and minimizes toxicity. In this study the investigators will evaluate the use of biweekly intravenous bevacizumab in combination with five oral drugs (thalidomide, celecoxib, fenofibrate, and alternating cycles of daily low-dose oral etoposide and cyclophosphamide), augmented with alternating courses of intrathecal etoposide and cytarabine. The aim of the study is to extend therapy options for children with recurrent or progressive medulloblastoma, ependymoma and ATRT, for whom no known curative therapy exists, by prolonging survival while maintaining good quality of life. The primary objective of the MEMMAT trial is to evaluate the activity of this multidrug antiangiogenic approach in these heavily pretreated children and young adults. Additionally, progression-free survival (PFS), overall survival (OS), as well as feasibility and toxicity will be examined.
Recruiting
1 award
Phase 2
More about Stewart Goldman, MD
Clinical Trial Related
9 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Stewart Goldman, MD has experience with
- Optune System
- BGB-290
- Temozolomide
- Nivolumab
- K27M Peptide
- CX-4945
Breakdown of trials Stewart Goldman, MD has run
Brain Tumor
Diffuse Intrinsic Pontine Glioma
Glioblastoma
Brain Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stewart Goldman, MD specialize in?
Stewart Goldman, MD focuses on Brain Tumor and Diffuse Intrinsic Pontine Glioma. In particular, much of their work with Brain Tumor has involved H3.3K27M positive patients, or patients who are IDH positive.
Is Stewart Goldman, MD currently recruiting for clinical trials?
Yes, Stewart Goldman, MD is currently recruiting for 2 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Stewart Goldman, MD has studied deeply?
Yes, Stewart Goldman, MD has studied treatments such as Optune System, BGB-290, Temozolomide.
What is the best way to schedule an appointment with Stewart Goldman, MD?
Apply for one of the trials that Stewart Goldman, MD is conducting.
What is the office address of Stewart Goldman, MD?
The office of Stewart Goldman, MD is located at: Lurie Children's Hospital-Chicago, Chicago, Illinois 60611 United States. This is the address for their practice at the Lurie Children's Hospital-Chicago.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.